ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
European Congress on Thrombosis and Haemostasis (ECTH) shared on LinkedIn:
”ECTH 2025 is officially LIVE in Prague
The first day is already buzzing with energy as the European Thrombosis and Haemostasis community reconnects in person.
The first day has kicked off with a buzz of excitement as attendees meet their peers, new faces join the community, and the halls in Prague fill with conversations and smiles.
Day 1 Highlights:
– The congress opened with a powerful plenary setting the tone for a science-driven and forward-looking programme.
– Early sessions explored real-world data in bleeding disorders, sparking lively debate and cross-disciplinary insights.
– The ECTH networking area is already a hub of activity, with early-career researchers exchanging ideas and building new networks.
Whether it’s catching up with colleagues, meeting new collaborators, or diving into the latest research, the ECTH community is back together and it feels great.
Stay tuned for snapshots, speaker moments, and more updates as the programme unfolds.
”
”Day 2 at ECTH 2025 has dawned with fresh energy and deeper conversations
As the ECTH 2025 congress venue fills once again, the community is diving into the heart of the programme; exchanging ideas, challenging perspectives, and building momentum for the future of thrombosis and haemostasis.
Programme highlights:
– This morning’s state-of-the-art sessions sparked discussions around haemophilia A, clonal haematopoiesis, von Willebrand disease and much more.
– A standout keynote lecture explored the understanding of the role of hemostasis in acute ischemic stroke treatment failure.
– The poster area is lively with energy from early-career researchers who are showcasing bold ideas and fresh data, and the conversations are flowing.
– And we are gearing up for tonight: the Congress Party! We are ready to unwind and celebrate with the community.
One more day to go!
Tomorrow promises even more inspiring sessions, networking moments, and community highlights.
Let’s keep the momentum going and close ECTH 2025 on a high note.
”
”And before we know it, the final moments of ECTH 2025 have just wrapped up
Three unforgettable days of science, stories, and shared purpose…what a ride it’s been. From early morning state-of-the-art sessions to late-night laughs, ECTH 2025 brought together brilliant minds and kind hearts in the most inspiring way.
We’ve explored the latest in thrombosis and haemostasis, challenged ideas, and sparked new collaborations.
The energy was inspiring, the conversations meaningful, and the community stronger than ever.
Whether you were presenting, listening, networking, or dancing at the congress party; THANK YOU for showing up, sharing generously, and making ECTH 2025 truly special.
To everyone who joined us in Prague: your passion, curiosity, and commitment made this experience unforgettable.
A heartfelt thank you also goes to our 19 sponsors and partners; your support made this congress possible and your presence added real value to the conversations and connections.
We’re grateful to have had you on this journey with us.
Next stop: ECTH 2027.
Until then, keep the connections alive, and keep the science moving.
”
More from ECTH 2025 featured in Hemostasis Today.
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 26, 2025, 15:39Lisa Murphy on Life After Stroke Sessions at WSC 2025
-
Oct 26, 2025, 15:21Patricia Simal Presented the Spanish National Health System's Stroke Strategy at WSC 2025
-
Oct 26, 2025, 14:32Paula Boldo on Sex-Stratified Genetic Risk of Stroke at WSC 2025
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 26, 2025, 12:24Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize
